Info@ThinkPinkRocks.com

Combination treatment for myocardial infarction shows no added benefit compared to ASA monotherapy

The drug ticagrelor has been approved since February 2016 for adults who had a myocardial infarction a year or more ago and are at a high risk of a new myocardial infarction or stroke.

Read more here:
Combination treatment for myocardial infarction shows no added benefit compared to ASA monotherapy

Share

Leave a Reply

Solve : *
21 + 13 =